6ème Congres International de Technologie Pharmaceutique: Paris, 2, 3 et 4 juin 1992 3 Exposés du 3 juin 1992, après-midi
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | German |
| Veröffentlicht: |
Châtenay Malabry
1992
|
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 503 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cc4500 | ||
|---|---|---|---|
| 001 | BV008317671 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 931105s1992 ad|| |||| 10||| gerod | ||
| 035 | |a (OCoLC)165136710 | ||
| 035 | |a (DE-599)BVBBV008317671 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-12 | ||
| 111 | 2 | |a Congres International de Technologie Pharmaceutique |n 6 |d 1992 |c Paris |j Verfasser |0 (DE-588)1225455-1 |4 aut | |
| 245 | 1 | 0 | |a 6ème Congres International de Technologie Pharmaceutique |b Paris, 2, 3 et 4 juin 1992 |n 3 |p Exposés du 3 juin 1992, après-midi |c organisé par Association de Pharmacie Galénique Industrielle |
| 264 | 1 | |c 1992 | |
| 264 | 1 | |a Châtenay Malabry | |
| 300 | |a 503 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 773 | 0 | 8 | |w (DE-604)BV008317665 |g 3 |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005495240&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-005495240 | ||
Datensatz im Suchindex
| _version_ | 1804122711287398400 |
|---|---|
| adam_text | IMAGE 1
6EMO CONGRES INTERNATIONAL
DE TECHNOLOGIE PHARMACEUTIQUE
6,H INTERNATIONAL CONFERENCE
ON PHARMACEUTICAL TECHNOLOGY
EXPOSES DU 3 JUIN 1992, APRES-MIDI
PAPERS ON 3 JUNE 1992, AFTERNOON
PARIS 2, 3 ET 4 JUIN 1992
PARIS 2, 3 AND 4 JUNE 1992
TIB/UB HANNOVER 89 129 609 358
IMAGE 2
8
MERCREDI, 3 JUIN 1992, APRES-MIDI/WEDNESDAY, 3 JUNE 1992, AFTERNOON
AMPHITHEATRE 1 VECTORISATION/TARGETING PAGE
14.10 PREPARATION AND OPTIMIZATION OF NANOPARTICLES BY A REVERSIBLE
SALTING-OUT PROCESS AVOIDING SURFACTANTS E. ALLEMAN, R. GUMY AND E.
DOELKER 15
14.30 STUDY OF THE MECHANISM OF PIBCA NANOPARTICLE AND NANOCAPSULE
FORMATION M.-M. GALLARDO, G. COUARRAZE, L TREUPEL, P. COUVREUR AND F.
PUISIEUX 22
14.50 PREPARATION OF DL LACTIDE/GLYCOLIDE COPOLYMER NANOSPHERES WITH A
WATER-INSOLUBLE OR SOLUBLE DRUG BY A NOVEL SPONTANEOUS EMULSIFICATION
SOLVENT DIFFUSION METHOD Y. KAWASHIMA, H. TAKEUCHI, T. NIWA, T. HINO
AND N. KUNO 32
15.10 ALGINATE NANOPARTICLES AS CARRIERS OF DRUGS M. RAJAONARIVONY, C.
VAUTHIER, F. PUISIEUX AND P. COUVREUR 41
15.30 PAUSE
16.00 DETERMINATION OF POLY(LACTIC ACID) NANOPARTICLE CONCENTRATION BY
SPECTROPHOTOMETRY P. HUVE, T. VERRECCHIA, D. BAZILE, G. SPENLEHAUER, M.
VEILLARD AND C. VAUTHIER 53
16.20 STUDY OF THE ADSORPTION OF OROSOMUCOID ON THE SURFACE OF
POLYISOBUTYL CYANOACRYLATE NANOPARTICLES J.C. OLIVIER, C. VAUTHIER, M.
TAVERNA, D. BAYLOCQ-FERRIER AND P. COUVREUR 62
16.40 ACTIVE TARGETING, POLYISOBUTYL CYANOACRYLATE NANOPARTICLES COUPLED
WITH A PEPTIDE CONTAINING RGDS M. ABERTURAS RAMOS, C. DUBEMET, A.
TARTAR, P. COUVREUR AND F. PUISIEUX 72
17.00 ANTI-METASTATIC ACTIVITY OF MURAMYL DIPEPTIDE-L-ALANYLCHOLESTEROL
INCORPORATED INTO VARIOUS TYPES OF NANOCAPSULE W.-P. YU, C. FOUCHER, G.
BARRATT, H. FESSI,J.-P. DEVISSAGUET AND F. PUISIEUX 83
IMAGE 3
9
17.20 CYTOTOXICITY AND UPTAKE OF FREE DOXORUBICIN AND DOXORUBICIN-LOADED
NANOPARTICLES IN SENSITIVE AND MULTIDRUG-RSISTANT LEUKAEMIC MURINE CELLS
F. NEMATI, A. COLIN DE VERDIERE, C. DUBERNET,
M.-F. POUPON, L TREUPEL, F. PUISIEUX AND P. COUVREUR 93
MERCREDI, 3 JUIN 1992, APRES-MIDI/WEDNESDAY, 3 JUNE 1992, AFTERNOON
AMPHITHEATRE 2 VOIE DERMIQUE/DERMAL ROUTE PAGE
14.10 RHEOLOGICAL PROPERTIES OF LAPONITE XLG, A SYNTHETIC PURIFIED
HECTORITE J. PLAIZIER-VERCAMMEN 105
14.30 THE EFFECTS OF A NUMBER OF SOLUTES AND POLYMERS ON THE
THERMORHEOLOGICAL PROPERTIES OF PLURONIC F 127 WATER DISPERSIONS S.
SRCIC, T. KRAMARIC, G. LAHAJNAR, B. KOFLER AND J. SMID-KORBAR 115
14.50 OPTIMIZATION AND IN VIVO ASSESSMENT OF A TOPICAL FORM OF A CALCIUM
CHANNEL BLOCKER BELONGING TO THE PHENYL DIHYDROPYRIDINE GROUP J.
COUTABLE AND M.-C. POELMAN 125
15.10 EVALUATION OF THE STABILITY OF INDOMETHACIN IN HYDROGELS G.
BOLLEN, M. BRISAERT AND J. PLAIZIER-VERCAMMEN 132
15.30 PAUSE
16.00 ANALYSIS OF MECHANISMS LEADING TO PROLONGED DRUG FLUXES IN
IONTOPHORESIS EXPERIMENTS M. CLEMESSY, G. COUARRAZE, C. HERRENKNECHT, B.
BEVAN AND F. PUISIEUX 142
16.20 DIFFUSIONAL, ELECTRIC AND ELECTRO-OSMOTIC CONTRIBUTIONS IN
IONTOPHORETIC TRANSPORT OF VERAPAMIL THROUGH ARTIFICIAL MEMBRANES P.
SANTI, P.L CATELLANI, G. MASSIMO AND P. COLOMBO 152
16.40 MECHANISM OF IONTOPHORETIC TRANSPORT ACROSS HAIRLESS RAT SKIN S.
THYSMAN AND V. PREAT 159
17.00 TRANSDERMAL ADMINISTRATION OF FENTANYL BY IONTOPHORESIS V. PREAT
AND S. THYSMAN 169
17.20 SKIN PERMEATION OF A HYDROPHOBE,
2,3,7,8-TETRACHLORODIBENZOP-DIOXIN (TCDD) M.S. RAHMAN, J.L ZATZ, M.A.
GALLO AND T.H. UMBREIT 178
IMAGE 4
10
MERCREDI, 3 JUIN 1992, APRES-MIDI/WEDNESDAY, 3 JUNE 1992, AFTERNOON
AMPHITHEATRE 5 COMPRIMES/TABLETS PAGE
14.10 MELT GRANULATION WITH A NEW LABORATORY HIGH-SHEAR MIXER B. EVRARD
AND L. DELATTRE 187
14.30 SCALE-UP OF A GRANULATION PROCESS IN A HIGH-SHEAR MIXER TURBO
SPHERE MORITZ B. HUET DE BAROCHEZ, L. ALBERTINI, P. GENTY, J.-B. MILERS,
M.-C. FRAISSE AND A. CUINE 197
14.50 AN APPROACH OF EXTRUSION AND SPHERONIZATION, COMPARISON OF TWO
EXTRUDERS BY MEANS OF EXPERIMENTAL DESIGNS E. LE DOEUFF, M. VANHOEVE,
A.T. GAYOT AND P. BECOURT 207
15.10 CAPACITY OF LIPOPHILIC AUXILIARY SUBSTANCES TO GIVE SPHERES BY
EXTRUSION/SPHERONIZATION A. EDIMO, P. LETERME, J. DENIS, M. TRAISNEL AND
A.T. GAYOT 216
15.30 PAUSE
16.00 SCALING-UP OF WET GRANULATION, A STATISTICAL APPROACH P. WEHRLE,
P. NOBELIS, A. CUINE AND A. STAMM 227
16.20 VALIDATION OF A NEW ROTARY TABLET MACHINE EQUIPPED WITH A
CENTRIFUGAL FEEDING DEVICE P.L CATELLANI, P. SANTI, N. GASPERIRII, S.
CICERI, G. DONDI AND P. COLOMBO 237
16.40 PRACTICAL INTEREST OF THE COHESION INDEX FOR THE
TECHNOLOGICAL FORMULATION OF TABLETS J.-C. GUYOT, L. TETE, S. TAK TAK
AND A. DELACOURTE 246
17.00 MATHEMATICAL MODELLIZATION OF THE COMPRESSION OF PHARMACEUTICAL
POWDERS G. BOURDIN, L CASAHOURSAT AND M.N. LE ROUX 254
17.20 PREPARATION OF SPHERICAL GRANULES FROM POLYOLS BY
EXTRUSION/SPHERONIZATION A. EDIMO, A.T. GAYOT AND J.M. NEWTON 262
IMAGE 5
11
MERCREDI, 3 JUIN 1992, APRES-MIDI/WEDNESDAY, 3 JUNE 1992, AFTERNOON
POSTERS LIBERATION PROLONGEE, ENROBAGE, SECHAGE SUSTAINED RELEASE,
COATING, DRYING PAGE
DEVELOPPEMENT GALENIQUE D UNE FORME MATRICIELLE A LIBERATION PROLONGEE
RENFERMANT UN PRINCIPE ACTIF HYDROSOLUBLE I. DELNEUVILLE, D. KAPUSTA,
J.-P. DECHESHE, B. EVRARD ETL DELATTRE 263
BIODISPONIBILITE DU NFAMPICINE DES FORMES PHARMACEUTIQUES ORALES I
POPOVICI, R. CUCIUREANU, V DOMEANU, AT. POPOVICI, A HNSCU, M. VASILESCU
ET M ROGOSCA 273
EFFECT OF GRANULE SIZE AND DELIVERY MODIFIER SUBSTANCES ON A PROLONGED
RELEASE DICLOFENAC SODIUM TABLET FORMULATION A. NAVARRO AND M P
BALLESTEROS 279
COMPARATIVE EVALUATION OF THE BIOPHARMACEUTICAL QUALITY OF PHENYTOIN
ORAL DOSAGE FORMS ON THE CHILEAN MARKET R. PEZOA, A.-M CONCHA, K.
OLBERTZ, V. DEL VILLARAND P. DIEZ 288
DISSOCIATION CONSTANT OF CHLORDIAZEPOXIDE IN MONTMORILLONITE SUSPENSIONS
AND ITS PHARMACEUTICAL APPLICATION FOR CONTROLLED-RELEASE DOSAGE FORMS A
M EL-SAYED, A -M I MOHAMED AND A ASSI 295
ETUDE DE L ACTIVITE PROLONGEE DE TROIS MATRICES LIPIDIQUES EN
COMPRESSION SELON UN PLAN D EXPERIENCES ET PAR ANALYSE DE DONNEES P.
PELLETIER, D GAUDY, B. ABRAMOVICI, J.M. RUIZ, J.P. REYNIER ET J. JOACHIM
305
ROLE DE L AGENT DE RETICULATION SUR LA LIBERATION DE MATRICES SPHENQUES
DE CARBOXY METHYLCELLULOSE RETICULEE V. LANNUCCELLI, F FORNI ET M -T
BERNABEI 314
OPTIMIZATION OF A SILICONE POLYMER FOR DRUG CONTROLLED RELEASE J.C.
MOREAU, J MAZAN, B. LECLERC, J L AVRIL AND G. COUARRAZE 323
INVESTIGATIONS ON ETHYL CELLULOSE AS AN ADDITIVE FOR SUSTAINED-RELEASE
FORMULATIONS T KURZ AND C. FUHRER 333
CARACTERISTIQUES DE DISSOLUTION DU CHLORHYDRATE DE DILTIAZEM A PARTIR DE
MATRICES HYDROPHILES RETARD DE SCLEROGLUCANE OBTENUES PAR COMPRESSION
DIRECTE G DASTE, A BEDOS, S. PLUMECOCQ ET P BARTHELEMY 340
IMAGE 6
12
DESIGN AND IN VIVO EVALUATION OF CONTROLLED-RELEASE FUROSEMIDE TABLETS
WITH CARBOMER 934 HYDROPHILIC MATRICES C. SOUTO, B. PEREZ-MARCOS, J.L
GOMEZ-AMOZA, R. MARTINEZ-PACHECO AND A. CONCHEIRO 349
A STUDY OF RELEASE PROFILES OF A NEW POLYMER BY RESPONSE SURFACES M.A.
ALONSO, P. FRUTOS AND G. FRUTOS 357
COMPRIMES MATRICIELS HYDROPHILES D ACIDE ACETYLSALICYLIQUE A LIBERATION
CONTROLEE, DEFINITION DE LA CONCENTRATION OPTIMALE EN POLYMERES
CELLULOSIQUES D. GAUDY, J.-P. MICHEL, O. ADAM, H. MAILLOLS, P. ROLLIM,
R. ACQUIER ET H. DELONCA 365
INFLUENCE OF THE POLYMER PERCENTAGE AND MANUFACTURING METHOD ON THE
THEOPHYLLINE RELEASE PROCESS A. RODRIGUEZ, P. FRUTOS AND G. FRUTOS 373
STUDY OF THE INFLUENCE OF THE TYPE OF DISSOLUTION METHOD ON DRUG IN
VITRO RELEASE KINETICS FROM OSMOTIC PUMPS C. CIVIALE, E. BEYSSAC, R.
RENOUX, G.K. SHIU AND J.-M. AIACHE 382
INFLUENCE OF DISSOLUTION SURFACE AND DRUG SOLUBILITY ON RELEASE FROM
MATRIX TABLETS AND MINI-TABLETS C. BROSSARD, V. RATSIMBAZAFY AND D.
LEFORT DES YLOUSES 391
RELEASE BEHAVIOUR AND MICROSTRUCTURE OF POLYGLYCOLIC ACID MICRO-TABLETS
F. MOLL AND R. RIES 401
IN VITRO/IN VIVO CORRELATIONS, LIMITS IN THE INTERPRETATION OF IN VITRO
DISSOLUTION TESTING IN ORDER TO COMPARE DRUG DOSAGE FORMS P. GAUTHIER,
E. BEYSSAC, S. AIACHE, E. GOUTAY, J. BOUGARET AND J.-M. AIACHE 410
IN VITRO/IN VIVO CORRELATIONS, STUDY OF THE DIFFERENT CORRELATION
LEVELS, APPLICATION TO SUSTAINED-RELEASE DOSAGE FORMS FORMULATED WITH AN
ANTI-HYPERTENSIVE DRUG E. BEYSSAC, P. GAUTHIER, F. GENTZBITTEL, E.
GOUTAY,
J. BOUGARET AND J.-M. AIACHE 418
ONSET OF ANALGESIC EFFECT AND TOLERABILITY OF A NEWER SUSTAINED-RELEASE
FORMULATION (DIFFUCAPS) OF DICLOFENAC SODIUM, A CONTROLLED CLINICAL
TRIAL G. CRISCUOLI, F. GIUNGI AND R. FABBRI 427
FORMULATION DE MINIGRANULES A LIBERATION MODIFIEE EN ROTOGRANULATEUR A
LIT D AIR FLUIDISE T. MAGNET, C. CHAUMAT ET M. ROLLET 436
RELEASE PROPERTIES OF IRON FROM SOLID ORAL DOSAGE FORMS, RELEVANCE TO
CONTENT UNIFORMITY A.E. EL-NIMR, M.S. ADEL AND R.M. KHALIL 446
IMAGE 7
13
CONTRIBUTION OF SCINTIGRAPHY TO VERIFY THE RELIABILITY OF DIFFERENT
PREPARATION PROCESSES FOR ENTERIC COATED CAPSULES D. CATTEAU, C.
BARTHELEMY, M. DEVEAUX AND H. VAN DRUNEN 454
USE OF MTC-LABELLED SUCRALPHATE TO STUDY THE BIOPHARMACEUTICAL
PROPERTIES OF ENTERIC COATED ASA TABLETS M. VIDGREN, H. RYTKONEN, K.
BERGSTROM, P. VAINIO
AND P. PARONEN 464
SECHAGE DES POUDRES SUR CYLINDRE, UNE METHODOLOGIE APPLICABLE A L ETUDE
DES PHENOMENES INTERVENANT LORS DU SECHAGE PAR CONDUCTION DE MATERIAUX
POREUX HYGROSCOPIQUES, CAS DES FEUILLES DE CELLULOSE
G. MORTHA, M. RUEFF ET R. CHARNEL 471
ETUDE ET INTERPRETATION DES CINETIQUES DE LYOPHILISATION PAR
L UTILISATION D UN MODELE MULTIPARAMETRIQUE DE BILLES DE VERRE N. FRATI,
P. LABOURET, G.N. CAVE, G. COUARRAZE ET F. PUISIEUX 479
APPROCHE DES PROBLEMES DE LYOPHILISATION DE SUBSTANCES A FAIBLE
PERMEABILITE DE VAPEUR PAR MODIFICATION DE LA STRUCTURE CRISTALLISEE AU
COURS DE LA CONGELATION F. NEMATI, G.N. CAVE ET P. COUVREUR 487
OPTIMISATION DE PARAMETRES DE LYOPHILISATION PAR ANALYSE CALORIMETRIQUE
DIFFERENTIELLE A. CARON, H. MIFSUD ET P. MONETON 494
|
| any_adam_object | 1 |
| author_corporate | Congres International de Technologie Pharmaceutique Paris |
| author_corporate_role | aut |
| author_facet | Congres International de Technologie Pharmaceutique Paris |
| author_sort | Congres International de Technologie Pharmaceutique Paris |
| building | Verbundindex |
| bvnumber | BV008317671 |
| ctrlnum | (OCoLC)165136710 (DE-599)BVBBV008317671 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01168nam a2200277 cc4500</leader><controlfield tag="001">BV008317671</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">931105s1992 ad|| |||| 10||| gerod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)165136710</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008317671</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">Congres International de Technologie Pharmaceutique</subfield><subfield code="n">6</subfield><subfield code="d">1992</subfield><subfield code="c">Paris</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)1225455-1</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">6ème Congres International de Technologie Pharmaceutique</subfield><subfield code="b">Paris, 2, 3 et 4 juin 1992</subfield><subfield code="n">3</subfield><subfield code="p">Exposés du 3 juin 1992, après-midi</subfield><subfield code="c">organisé par Association de Pharmacie Galénique Industrielle</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1992</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Châtenay Malabry</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">503 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="w">(DE-604)BV008317665</subfield><subfield code="g">3</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005495240&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005495240</subfield></datafield></record></collection> |
| id | DE-604.BV008317671 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:18:13Z |
| institution | BVB |
| institution_GND | (DE-588)1225455-1 |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005495240 |
| oclc_num | 165136710 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 503 S. Ill., graph. Darst. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| record_format | marc |
| spelling | Congres International de Technologie Pharmaceutique 6 1992 Paris Verfasser (DE-588)1225455-1 aut 6ème Congres International de Technologie Pharmaceutique Paris, 2, 3 et 4 juin 1992 3 Exposés du 3 juin 1992, après-midi organisé par Association de Pharmacie Galénique Industrielle 1992 Châtenay Malabry 503 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier (DE-604)BV008317665 3 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005495240&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | 6ème Congres International de Technologie Pharmaceutique Paris, 2, 3 et 4 juin 1992 |
| title | 6ème Congres International de Technologie Pharmaceutique Paris, 2, 3 et 4 juin 1992 |
| title_auth | 6ème Congres International de Technologie Pharmaceutique Paris, 2, 3 et 4 juin 1992 |
| title_exact_search | 6ème Congres International de Technologie Pharmaceutique Paris, 2, 3 et 4 juin 1992 |
| title_full | 6ème Congres International de Technologie Pharmaceutique Paris, 2, 3 et 4 juin 1992 3 Exposés du 3 juin 1992, après-midi organisé par Association de Pharmacie Galénique Industrielle |
| title_fullStr | 6ème Congres International de Technologie Pharmaceutique Paris, 2, 3 et 4 juin 1992 3 Exposés du 3 juin 1992, après-midi organisé par Association de Pharmacie Galénique Industrielle |
| title_full_unstemmed | 6ème Congres International de Technologie Pharmaceutique Paris, 2, 3 et 4 juin 1992 3 Exposés du 3 juin 1992, après-midi organisé par Association de Pharmacie Galénique Industrielle |
| title_short | 6ème Congres International de Technologie Pharmaceutique |
| title_sort | 6eme congres international de technologie pharmaceutique paris 2 3 et 4 juin 1992 exposes du 3 juin 1992 apres midi |
| title_sub | Paris, 2, 3 et 4 juin 1992 |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005495240&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV008317665 |
| work_keys_str_mv | AT congresinternationaldetechnologiepharmaceutiqueparis 6emecongresinternationaldetechnologiepharmaceutiqueparis23et4juin19923 |